Yazım Kuralları

The Marmara Medical Journal publishes original scientific research papers, case reports, manuscripts about clinical and practical applications and editorials, short reports, letters, and occasionally a photo quiz.

Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out.

Manuscripts are accepted for review with the understanding that no substantial portion of the study has been published or is under consideration for publication elsewhere.
The Marmara Medical Journal is in compliance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals created by the International Committee for Medical Editors ( ICMEJ link), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE) and the European Association of Science Editors (EASE).


Preparation of the manuscript

Manuscript files must be prepared in Word, WordPerfect, EPS, LaTeX, text, Postscript, or RTF format. Figures/Images should be embedded in the manuscript file or sent as external files in TIFF, GIF, JPG, BMP, Postscript, or EPS format. Manuscripts should be approximately 20-25 pages double-spaced, including references, with margins of 2.5 cm.



Pages should be numbered consecutively and organized as follows:


1. Title Page
2. Abstract
3. Keywords
4. Introduction
5. Materials and Methods
6. Results
7. Conclusion
8. References

1. Title page
The title page should contain the article title, authors' names and academic or professional affiliations, and the address for manuscript correspondence (including e-mail address, Open Researcher and Contributor ID (ORCID) identifier, telephone and fax numbers).

Submit the Title Page containing the Author's details and Blinded Manuscript with no author details as 2 separate files.

2. Abstract
Abstract of not more than 200 words must be included. The abstract should be divided into the following sections: Objective, Materials and Methods, Results and Conclusion.

3. Keywords
Three –to six keywords should be taken from Medical Subject Headings (MeSH) from Index Medicus.

4. Introduction
State why the investigation was carried out, note any relevant published work and delineate the objective of the investigation.
5. Materials and Methods
New methods or significant improvements of methods or changes in old methods must be described. Methods for which an adequate reference can be cited are not to be described, except for providing information about the aims of the method. Details regarding animal housing conditions should be given.

All clinical studies must contain :

A statement that all experimental protocols have been approved by the Ethical Committee of the Institution prior to the commencement of the studies.

A statement that all participants gave informed consent.

6. Results

Duplication between the text of this section and material presented in tables and figures should be avoided. Tabular presentation of masses of negative data must be avoided and replaced with a statement in the text whenever possible. The results must be presented clearly, concisely, and without comment.

7. Discussion

The discussion should begin with a brief summary of the findings, followed by the following: how this study is similar or different from prior studies with regards to methods and results and limitations of this study. This section must also relate the significance of the work to existing knowledge in the field and indicate the importance of the contribution of this study.

8. References
The style of references is that of the Index Medicus. List all authors when there are six or fewer, when there are seven or more list the first three, then add "et al.". Unpublished results or personal communications should be cited as such in the text. Where a doi number is available it must be included at the end of the citation.

Please note the following examples:


Yazici D, Taş S, Emir H, Sunar H. Comparison of premeal mixed insulin three times daily and basal-bolus insulin therapy started post-operatively on patients having coronary artery bypass graft surgery. Marmara Med J 2011; 25:16-9.doi: 10.5472/
Walker M, Hull A. Preterm labor and birth. In: Taeusch HW, Ballard RA, eds. Avery's Diseases of the Newborn. Philadelphia: WB Saunders, 1998: 144,153.
Hagström H, Nasr P, Ekstedt M, et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol 2017; 67: 1265-73. doi: 10.1016/j.jhep.2017.07.027.
WONCA Ad Hoc Task Force on Tobacco Cessation. http://globalfamilydoctor.com/publications/new/november/09.htm. (Accessed on …….)

In the text, reference numbers should be placed in square brackets [ ], and placed before the punctuation; for example [1], [1-3], or [1,3].



Figures, Tables, Units

Diagrams and illustrations should be given Arabic numerals. All figure legends should be grouped and written on a separate page. Each Figure should be in one of the following preferred formats: Tiff, JPEG, PDF, and EPS.

Tables should be numbered consecutively with Roman numerals in order of appearance in the text. Type each table double-spaced on a separate page with a short descriptive title directly above and with essential footnotes below.
Units will be in general accordance with the International System (SI) as adopted by the 11th General Conference on Weights and Measures.


Ethical Issues

Compliance with the principles of the last version of the Declaration of Helsinki for humans and the European Community guidelines for the use of animals in experiments is accepted as a policy by the Marmara Medical Journal. Studies involving human or animal subjects should conform to national, local, and institutional laws and requirements. Manuscripts that do not properly consider ethical issues for humans or animals will not be accepted for publication.

Double-blind Review

This journal uses a double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. To facilitate this, authors need to ensure that their manuscripts are prepared in a way that does not give away their identity.

Plagiarism
Manuscripts are investigated for possible plagiarism once they are accepted for possible publication. If an author receives a plagiarism notice regarding his/her manuscript, the corrections should be made within one month. If the Editorial Board detects any plagiarism on the second check after correction of the manuscript by the authors, the chief editor can reject the manuscript. your article will be checked by the plagiarism detection software iThenticate.



Funding Source

All sources of funding should be declared as an acknowledgment at the end of the text.

Following documents are required prior to publication

Approval of the Institutional Ethics Committee

a) Marmara Medical Journal requires that investigations performed on human subjects have the prior approval of the Institutional Ethics Committee on Human Experimentation. Authors are required to submit a signed statement as to the date and details of the appropriate review.
b) When studies involve the use of experimental animals, manuscripts should briefly describe the procedures employed for animal care and handling. Where drugs are used at particular concentrations in intact animal systems, the author should indicate some rationale for the selection of the particular concentration.
Copyright Release Form

Copyright Release Form must be read and signed by all authors.

Copyright Relaese Form pdf

Authorship


It is the responsibility of every researcher listed as an author of a manuscript in Marmara Medical Journal to have contributed in a meaningful and identifiable way to the design, performance, analysis, and reporting of the work and to agree to be accountable for all aspects of the work.

Before publication, each author must sign a statement attesting that he or she fulfills the authorship criteria of the ICMJE Recommendations.

http://www.icmje.org/recommendations/

Financial Associations/Conflicts of Interest

All participants - not only the corresponding author- must consider their conflicts of interest when fulfilling their roles in the process of article preparation and must disclose all relationships that could be viewed as potential conflicts of interest according to the Committee on Publication Ethics (COPE) Guidelines and/ or Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE) Recommendations. Disclosure forms filed by all authors alongside the full text of each article are mandatory.

https://publicationethics.org/guidance/Guidelines
http://www.icmje.org/recommendations/

We encourage the authors on using the ICMJE Form for Disclosure of Conflicts of Interest to standardize authors’ disclosures.

Conflict of Interest Form.pdf

Statement of Human Rights and Statement of Animal Rights

Statement of human rights and statement of animal rights, when necessary, must be signed by all authors prior to publication.

Statement of human and animal rights form.pdf


Patient Consent for Publication

Patients have a right to privacy. Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, photographs or in any kind of patient-related materials. In circumstances where this information is essential for scientific purposes, authors should obtain the patient’s (or the legal guardian’s) written informed consent prior to the publication.

Patient Consent for Publication pdf



Marmara Medical Journal
Copyright Release Form


"The enclosed manuscript (Title) has been approved by me as well as by the responsible authorities at the institute where the work has been carried out. I certify that none of the material in this manuscript has been published previously in any form and that none of this material is currently under consideration for publication elsewhere. This includes symposia and proceedings of meetings and preliminary publications of any kind, except an abstract of 400 words or less."

Author Name Signature Date

-----------------------------------------------------

-----------------------------------------------------

-----------------------------------------------------

-----------------------------------------------------


Statement for Conflict of Interest:



Please clearly state below whether or not there are any conflicts of interest regarding the submission and publication of the manuscript and its potential implications.

Title of the Manuscript:

---------------------------------------------------------------------------------------------------------




Statement:
---------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------






Name Signature Date

-----------------------------------------------------

-----------------------------------------------------

-----------------------------------------------------

-----------------------------------------------------


(http://www.wma.net/en/30publications/10policies/b3/index.html